期刊文献+

静脉应用胺碘酮治疗老年冠心病并发快速心律失常疗效观察 被引量:20

Effect of amiodarone in elderly patients with coronary heart disease and tachyarrhythmia
下载PDF
导出
摘要 目的探讨胺碘酮治疗老年冠心病患者合并快速心律失常的临床疗效,了解胺碘酮对血流动力学的影响。方法78例老年冠心病患者,发生快速心律失常后首剂静注负荷剂量3~5mg/kg,5~10min注入,继之以微量泵维持,如无效,15min后可再次予1~1.5mg/kg胺碘酮静注,前6h1mg/min维持,其后以0.5mg/min维持,24h总剂量900~1200mg。其中7例患者插入Swan-Ganz漂浮热稀释导管,用GEsolar9500心电监护仪及配套血流动力学插件测定和计算各项血流动力学指标。结果静脉应用胺碘酮后显效53例(67.9%),有效69例(88.4%);7例患者血流动力学监测静脉应用胺碘酮前后动脉血压、平均肺动脉压、肺毛细血管嵌压、心指数差异无统计学意义。结论胺碘酮对冠心病合并快速心律失常的老年患者血流动力学影响较小,可有效而安全的用于这些患者的抢救。 Objective To investigate the effect of amiodarone in elderly patients with coronary heart disease and tachyarrhymia. Methods 78 patients received amiodarone at a dosage of 3-5 mg/kg iv in 5-10 rain, followed by continue pumping at 1 rag/rain for the first 6 hours and 0.5mg/min there after. Seven patients inserted with Swan-Ganz floating hot dilated catheter. The pulmonary artery pressure (MPAP), pulmonary capillary wedge pressure (PCWP) and cardiac index (CI) were record before and after amiodarone treatment. Results The efficiency rate is 88.4% in amiodarone group. The hemodynamic records indicated that pulmonary artery pressure (MPAP), pulmonary capillary wedge pressure (PCWP) and cardiac index (CI) have no significant change. Conclusion The use of amiodarone is effective and safe on elderly patients with coronary heart disease.
出处 《中国心血管病研究》 CAS 2006年第3期194-196,共3页 Chinese Journal of Cardiovascular Research
关键词 心律失常 冠心病 老年人 胺碘酮 Arrhythmia Coronary disease, aged Amiodarone
  • 相关文献

参考文献7

  • 1[1]Massie BM,Fisher SG,Radford M,et al.Effect of amiodarone on clinical atatus and left ventricular function in patients with congestive heart failure.Circulation,1996,93:2128-2134.
  • 2孙丽娟,王建春.胺碘酮在老年人心律失常中的应用[J].实用诊断与治疗杂志,2005,19(2):123-125. 被引量:22
  • 3[3]Nademauce K.The Amiodarone Odyssey.J AM Coll Cardiol,1992,20:1063.
  • 4[4]The Cardiac Arrhythmia Suppression Trial Ⅱ Investigators.Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.N Engl J Med,1992,327:227-233.
  • 5[5]Cotter G,Blatt A,Kaluski E,et al.Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm:the effect of no treatment and high-dose amiodarone.A randomized,placebo -controlled study.Eur Heart J,1999,20:1833-1842.
  • 6[6]Rathore SS,Berger AK,Weinfurt KP,et al.Acute myocardial infarction by atrial fibrillation in the elderly:prevalence and outcomes.Circulation,2000,101:969.
  • 7彭赟,杨丹鹰.静脉注射胺碘酮与普罗帕酮转复阵发性心房颤动的疗效比较[J].中国心血管病研究,2004,2(5):344-346. 被引量:5

二级参考文献15

  • 1陈修 陈维洲 等.心血管药理学[M].北京:人民卫生出版社,1997.324-325.
  • 2[1]Kannel WB, Abbott RD,Savage DD, et al. Epideminologic features of chronic atrial: the Framingham study[J]. N Engl J Med, 1982,306:1018- 1022
  • 3[2]Benjamin EJ,Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham heart study[J ]. Circulation, 1998,98: 946 - 952
  • 4[3]Wolf PA, Mitchell JB, Baker CS, et al. Impact of atrial fibrillation on mortality, stroke and medical costs [ J ].Arch Intern Med, 1998,158: 229 - 234
  • 5[4]Sopher SM, Camm AJ. Atrial fibrillation: maintenance of sinus rhythm versus rate control [ J ]. Am J Cardiol,1996,77: 24A- 37A
  • 6[6]S Levy, G Breithardt, R W F. Campbell, at al. Atrial fibrillation: current knowledge and recommendations for management [J ]. Eur Heart J, 1998, 19:1294 -1320
  • 7[7]Kreiss Y, Sidi Y, Gur H. Efficacy and safety of intravenous arniodarone in recent onset atria fibrillation:experience in patients admitted to a general internal medicine department [ J ]. Postgrad Med J, 1999, 75(2) :278 - 281
  • 8[9]Reiffel JA. lntravenous amioxdarone in the management of atrial fibrillation[J ]. J Cardiovasc Pharmacol Ther,1999,4(4): 199 - 204
  • 9[10]Bellandi F, Cantini F, Pedone T, et al. Effectiveness of lntravenous propafenone for conversion of recent - onset atrial fibrillation: a placebo - controlled study[J ].Clin Cardiol, 1995,18(11) :631 - 634
  • 10[11]Fresco C, Proclemer A, Pavan A, et al. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo - controlled, double - blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian trial(PAFIT) - 2 lnvestigators[J ]. Clin Cardiol, 1996, 19(5) :409 - 412

共引文献25

同被引文献74

引证文献20

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部